Bruker Cellular Analysis, Inc.
CELLDelisted Oct 2, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001689657
Bruker Cellular Analysis, Inc. was delisted on Oct 2, 2023; its insiders filed their last Form 4 on Oct 3, 2023; 57 institutions reported holding it in 13F filings for Q3 2023, worth $35.8M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Bruker Cellular Analysis, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 117 | 1 | 103 | −13 |
| Shares | 48.6M | 50 | 54.6M | +5.91M (+12.2%) |
| Value | $130.4M | $134 | $63.3M | −$67.0M (−51.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Bruker Cellular Analysis, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northpond Ventures, LLC | 5,390,820 | $6.25M | 3.57% |
| Perceptive Advisors LLC | 2,506,442 | $2.91M | 0.09% |
| Norges Bank | 384,948 | $446.5K | 0.00% |
| Water Island Capital LLC | 66,000 | $76.6K | 0.01% |
| Yale University | 65,654 | $76.2K | 0.17% |
| Quadrant Private Wealth Management, LLC | 54,562 | $63.3K | 0.02% |
| South Dakota Investment Council | 51,465 | $60.0K | 0.00% |
| Vident Investment Advisory, LLC | 24,355 | $28.3K | 0.00% |
| Klingman & Associates, LLC | 13,005 | $15.1K | 0.00% |
| Algert Global LLC | 12,751 | $14.8K | 0.00% |
| Close Asset Management Ltd | 3,460 | $4.00K | 0.00% |
| Compass Wealth Management LLC | 2,242 | $2.60K | 0.00% |
| Slow Capital, Inc. | 1,000 | $1.16K | 0.00% |
| Ronald Blue Trust, Inc. | 470 | – | – |
Sold out (27)
Institutions that held Bruker Cellular Analysis, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held Bruker Cellular Analysis, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Sargent Bickham Lagudis LLC | 50 | $134 |